Clinical Trial Update: Two-cohort Study of Toripalimab(PD1)+Lenvatnib, or Gemox+Lenvatinib in Advanced Intrahepatic Cholangiocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating two regimens—toripalimab with lenvatinib, or gemcitabine/oxaliplatin with lenvatinib—in advanced intrahepatic cholangiocarcinoma has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Lenvatinib (lenvatinib)
• OXALIPLATIN (Oxaliplatin)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Cholangiocarcinoma, Intrahepatic | Phase 2 | Status: COMPLETED